UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How I treat autoimmune lymphoproliferative syndrome

Blood, 2011-11, Vol.118 (22), p.5741-5751

2011

Volltextzugriff (PDF)

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities

Blood, 2015-04, Vol.125 (18), p.2753-2758

2015

Volltextzugriff (PDF)

Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations

Blood, 2015-01, Vol.125 (4), p.591-599

2015

Volltextzugriff (PDF)

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop

Blood, 2010-10, Vol.116 (14), p.e35-e40

2010

Volltextzugriff (PDF)

Vaccine utilization and overwhelming post-splenectomy infection risk factors in two asplenia cohorts

Haematologica (Roma), 2024-02, Vol.109 (2), p.622-626

2024

Volltextzugriff (PDF)

Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis

Blood, 2011-03, Vol.117 (10), p.2883-2886

2011

Volltextzugriff (PDF)

Evans syndrome: pathology and genomic hubris

Blood, 2022-01, Vol.139 (3), p.312-313

Rao, V. Koneti

2022

Volltextzugriff (PDF)

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome

Blood, 2010-06, Vol.115 (25), p.5164-5169

2010

Volltextzugriff (PDF)

Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation

Haematologica (Roma), 2017-02, Vol.102 (2), p.364-372

2017

Volltextzugriff (PDF)

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome

British journal of haematology, 2005-05, Vol.129 (4), p.534-538

2005

Volltextzugriff (PDF)

Primary immunodeficiencies: novel genes and unusual presentations

Hematology, 2019-12, Vol.2019 (1), p.443-448

2019

Volltextzugriff (PDF)

Serendipity in splendid isolation: rapamycin

Blood, 2016-01, Vol.127 (1), p.5-6

Rao, V. Koneti

2016

Volltextzugriff (PDF)

Spleen is cool

Pediatric hematology and oncology, 2019-08, Vol.36 (6), p.327-329

Rao, V. Koneti

2019

Volltextzugriff (PDF)

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations

Blood, 2014-03, Vol.123 (13), p.1989-1999

2014

Volltextzugriff (PDF)

ITP: hematology's Cosette from Les Misérables

Blood, 2013-03, Vol.121 (11), p.1928-1930

Rao, V. Koneti

2013

Volltextzugriff (PDF)

Clinical Challenges: Identification of Patients With Novel Primary Immunodeficiency Syndromes

Journal of pediatric hematology/oncology, 2018-07, Vol.40 (5), p.e319-e322

2018

Volltextzugriff (PDF)

Causes and consequences of the autoimmune lymphoproliferative syndrome

Hematology (Luxembourg), 2006-02, Vol.11 (1), p.15-23

2006

Volltextzugriff (PDF)

Treating Rosai–Dorfman disease and RAS‐associated autoimmune leucoproliferative disorder with malignant transformation

British journal of haematology, 2021-02, Vol.192 (3), p.667-671

2021

Volltextzugriff (PDF)

Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome

Blood advances, 2024-06, Vol.8 (12), p.3092-3108

2024

Volltextzugriff (PDF)

Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI

Leukemia research, 2003-08, Vol.27 (8), p.677-682

2003

Volltextzugriff (PDF)

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)

Pediatric Blood & Cancer, 2009-07, Vol.52 (7), p.847-852

2009

Volltextzugriff (PDF)

Fluorodeoxyglucose positron emission tomography (FDG‐PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS)

American journal of hematology, 2006-02, Vol.81 (2), p.81-85

2006

Volltextzugriff (PDF)

Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr−/− murine model of autoimmune lymphoproliferative syndrome (ALPS)

Experimental hematology, 2009-04, Vol.37 (4), p.487-494

2009

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Allergy And Clinical Immunology

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Humans
(27)
Female
(15)
Male
(15)
Biological And Medical Sciences
(12)
Child
(12)
Adult
(11)
Medical Sciences
(11)
Child, Preschool
(10)
Adolescent
(8)
Hematologic And Hematopoietic Diseases
(8)
Middle Aged
(7)
Mutation
(7)
Young Adult
(6)
Autoimmune Diseases - Immunology
(5)
Fas Receptor - Genetics
(5)
Infant
(5)
Lymphoproliferative Disorders - Immunology
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

How I treat autoimmune lymphoproliferative syndrome

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities

Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop

Vaccine utilization and overwhelming post-splenectomy infection risk factors in two asplenia cohorts

Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

Evans syndrome: pathology and genomic hubris

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome

Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome

Primary immunodeficiencies: novel genes and unusual presentations

Serendipity in splendid isolation: rapamycin

Spleen is cool

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations

Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function

ITP: hematology's Cosette from Les Misérables

Clinical Challenges: Identification of Patients With Novel Primary Immunodeficiency Syndromes

Causes and consequences of the autoimmune lymphoproliferative syndrome

Treating Rosai–Dorfman disease and RAS‐associated autoimmune leucoproliferative disorder with malignant transformation

Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome

Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)

Fluorodeoxyglucose positron emission tomography (FDG‐PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS)

Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr−/− murine model of autoimmune lymphoproliferative syndrome (ALPS)

Aktive Filter

Suchergebnisse filtern